Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
Karuna Therapeutics, Inc. (KRTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/20/2022 SC 13D/A ARCH Venture Fund IX, L.P. has filed a Schedule 13D for Karuna Therapeutics, Inc.
08/12/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/09/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/12/2021 SC 13D/A PureTech Health LLC reports a 5.6% stake in Karuna Therapeutics, Inc.
04/22/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/10/2021 SC 13D/A PureTech Health plc reports a 9% stake in Karuna Therapeutics, Inc.
01/19/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/26/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/26/2020 SC 13D/A PureTech Health LLC reports a 18.1% stake in Karuna Therapeutics, Inc.
12/13/2019 SC 13D/A ARCH Venture Fund IX, L.P. reports a 12.9% stake in Karuna Therapeutics, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy